Skip to content

Alternative IntraOsseous Infusion Randomised controlled trial comparing 3 intraosseous methods

Alternative IntraOsseous Infusion Randomised controlled trial comparing 3 intraosseous methods - AIOT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29822
Enrollment
150
Registered
2006-06-15
Start date
2006-06-20
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute/Spoedeisende situaties, waarbij inbrengen van een intraveneus infuus essentieel, maar niet mogelijk is polytrauma

Interventions

The intervention consists of the application of a randomized bone needle. - In people >= 14 years: BIG vs FAST vs conventional bone needle. - In children

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients in acute life threatening situations, requiring assistance of a mobile medical team. These patients need to be reanimated, or placement of an intravenous infusion has been insuccessful in two attempts.

Exclusion criteria

Exclusion criteria: Patients with suspected sternumanomaly; large skin defects, skin infection or fracture at the site of the insertion location; two or more placed bone needles

Design outcomes

Primary

MeasureTime frame
Primary endpoint: aspiration of bone marrow upon placement of a bone needle. Primary parameter is: time required for successful placement.

Secondary

MeasureTime frame
Secundary endpoint: complications of the bone needle used. Secundary parameters are: complications, success rates, user friendliness, pain encountered by the patient.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)